Epigenetically altered miR‐193b targets cyclin D1 in prostate cancer-Reference-Cited by-同舟云学术

Epigenetically altered miR‐193b targets cyclin D1 in prostate cancer

Published:2015-07 Issue:9 Volume:4 Page:1417-1425
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Kaukoniemi Kirsi M.¹²,Rauhala Hanna E.¹,Scaravilli Mauro¹²,Latonen Leena¹²,Annala Matti¹,Vessella Robert L.³,Nykter Matti¹,Tammela Teuvo L. J.⁴,Visakorpi Tapio¹²

Affiliation:

1. Institute of Biosciences and Medical Technology ‐ BioMediTech University of Tampere Tampere Finland

2. Fimlab Laboratories Tampere University Hospital Tampere Finland

3. Department of Urology University of Washington Seattle Washington

4. Department of Urology University of Tampere and Tampere University Hospital Tampere Finland

Funder

Tampere University Doctoral Programme in Biomedicine and Biotechnology

Sigrid Juselius Foundation

Finnish Cultural Foundation

Pirkanmaa Regional fund

Academy of Finland

Cancer Society of Finland

Medical Research Fund of Tampere University Hospital

European Community's Seventh Framework Programme ProspeR

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.486

Reference36 articles.

1. Global cancer statistics

2. Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancer

3. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

4. MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review

5. An Extensive Class of Small RNAs in Caenorhabditis elegans

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tiny Guides, Big Impact: Focus on the Opportunities and Challenges of miR-Based Treatments for ARDS;International Journal of Molecular Sciences;2024-02-28

2. Liquid biopsy utilizing miRNA in patients with advanced breast cancer treated with cyclin‑dependent kinase 4/6 inhibitors;Oncology Letters;2024-02-28

3. MicroRNA´S COMO BIOMARCADORES DO CÂNCER DE PRÓSTATA: UMA REVISÃO INTEGRATIVA;REVISTA FOCO;2023-11-16

4. In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer;Biomedicines;2023-10-05

5. Epigenetic Downregulation of Hsa-miR-193b-3p Increases Cyclin D1 Expression Level and Cell Proliferation in Human Meningiomas;International Journal of Molecular Sciences;2023-08-30